What was Cencora called before?
Cencora, a massive American multinational drug wholesale corporation and pharmaceutical services provider, operated under the corporate name AmerisourceBergen Corporation prior to its comprehensive global rebrand. Formed originally in 2001 through a multi-billion dollar merger of equals between Amerisource Health Corporation and Bergen Brunswig Corporation, the enterprise grew to become an essential linchpin of the global healthcare supply chain, distributing pharmaceuticals, medical supplies, and providing healthcare consulting services worldwide. To reflect its modern international footprint, unified corporate strategy, and expanding focus beyond its legacy founding names, corporate leadership officially announced the name change to Cencora. This corporate rebranding effort was designed to signal a forward-looking identity while maintaining its core position as a global healthcare powerhouse connecting pharmaceutical manufacturers with healthcare providers everywhere.
Related FAQs
Cencora (formerly AmerisourceBergen) is a massive global healthcare solutions company and pharmaceutical wholesale distributor that manages a comprehensive portfolio of subsidiary enterprises.
The Cencora security incident refers to a major data breach and cyberattack involving unauthorized exfiltration of sensitive consumer and corporate data from the pharmaceutical solutions and drug wholesale enterprise.
Someone can potentially access your bank account using your physical debit card if they also possess your Personal Identification Number or if they use the card for unauthorized contactless or online transactions that do not strictly require a PIN.
Coromandel International Limited, a prominent player in the agricultural solutions, phosphatic fertilizers, and crop protection sector, follows a consistent annual dividend distribution policy.
Union members who leave their jobs or quit before reaching retirement age do not necessarily lose their pension benefits, provided they have met the plan's vesting requirements.
When purchasing standard, non-leveraged, long positions in Bitcoin on eToro using cash balances, investors are investing in the underlying asset, meaning the platform purchases and holds the actual tokens on their behalf in a secure omnibus wallet.
Under class-action data breach settlement terms related to Cencora incidents, participating class members can submit claims for documented out-of-pocket losses, receiving reimbursement up to $5,000 per person for verified unreimbursed expenses or los...
Centene Corporation demonstrates solid operational and financial performance, anchoring its market position as a leading healthcare enterprise focusing on government-sponsored healthcare programs, including Medicaid, Medicare, and the Health Insuranc...
Legal and financial settlements involving Cencora, formerly known as AmerisourceBergen, typically relate to comprehensive multi-state and federal litigation concerning opioid distribution practices and regulatory compliance frameworks.
Wall Street equity analysts generally maintain a favorable buy or moderate accumulation consensus rating for Cencora, one of the world's leading global healthcare solutions and pharmaceutical distribution enterprises.
A single share of EPR Properties (NYSE: EPR) trades at approximately $63.53 USD.
Cencora, Inc.
Equity research analysts tracking Cencora, Inc. (COR) maintain a consensus Buy rating, with average 12-month price targets clustering around $350.58 to $357.00 per share, and upper estimates reaching up to $374.00.
Equities that historically demonstrate resilience or defensive outperformance during broad market crashes typically belong to non-cyclical sectors such as consumer staples, utilities, healthcare, and discount retail.
Cencora is widely regarded as an exceptional, highly reputable enterprise that plays a critical role in global healthcare by distributing life-saving medications, medical products, and digital healthcare solutions safely across international markets.
Cencora, Inc. (formerly known as AmerisourceBergen), a global leader in pharmaceutical sourcing, distribution, and clinical service solutions, is headquartered in Conshohocken, Pennsylvania, United States.
Legal settlements and class-action notices associated with Cencora (formerly AmerisourceBergen) regarding corporate data security incidents or regulatory compliance matters are entirely legitimate legal developments.
Cencora officially ranks as a top-tier Fortune 10 company, securing a prestigious position among the absolute largest corporations in the United States by total annual revenue.